We hence turned to a cohort of ccRCC patients that had undergone nephrectomy (Supplementary Table 1) to explore the role of the SEMA3A/NRP1 pathway in human cancer immunity (Fig. 6b). This evidence concerns the gene SEMA3A and nonpapillary renal cell carcinoma.